Total Payments
$1,263
2024 Payments
$233.97
Companies
22
Transactions
81
Medicare Patients
2,496
Medicare Billing
$395,181
Payment Breakdown by Category
Food & Beverage$1,258 (99.6%)
Education$5.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,258 | 80 | 99.6% |
| Education | $5.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $351.51 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $182.64 | 4 | $0 (2017) |
| Abbott Laboratories | $96.04 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $95.21 | 1 | $0 (2017) |
| Amneal Pharmaceuticals LLC | $92.23 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $53.93 | 4 | $0 (2022) |
| IBSA Pharma Inc. | $52.30 | 4 | $0 (2024) |
| Lilly USA, LLC | $49.51 | 4 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $39.90 | 3 | $0 (2024) |
| ABBVIE INC. | $36.84 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.97 | 15 | Novo Nordisk Inc ($51.95) |
| 2023 | $66.90 | 5 | Abbott Laboratories ($14.58) |
| 2022 | $171.06 | 13 | Amneal Pharmaceuticals LLC ($38.13) |
| 2021 | $265.54 | 12 | Novo Nordisk Inc ($139.57) |
| 2020 | $12.26 | 1 | Lilly USA, LLC ($12.26) |
| 2019 | $12.75 | 1 | SANOFI-AVENTIS U.S. LLC ($12.75) |
| 2018 | $38.01 | 3 | Shire North American Group Inc ($26.42) |
| 2017 | $463.00 | 31 | AstraZeneca Pharmaceuticals LP ($182.64) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 08/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Endocrinology | ||||||
| 08/16/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Rare Disease | ||||||
| 07/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ENDOCRINE AGENT | ||||||
| 05/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Insulin Pump | ||||||
| 05/10/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes Care | ||||||
| 03/01/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Endocrinology | ||||||
| 02/09/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/26/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Rare Disease | ||||||
| 11/16/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Diabetes | ||||||
| 09/12/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes Care | ||||||
| 04/21/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: non-opioid analgesic | ||||||
| 03/31/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $11.71 | General |
| Category: Endocrinology | ||||||
| 12/09/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $11.71 | General |
| Category: Endocrinology | ||||||
| 12/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Diabetes Care | ||||||
| 08/12/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 576 | 1,077 | $225,849 | $94,244 |
| 2022 | 5 | 620 | 1,185 | $177,535 | $108,775 |
| 2021 | 5 | 649 | 1,110 | $167,570 | $105,789 |
| 2020 | 4 | 651 | 1,119 | $166,410 | $86,374 |
Total Patients
2,496
Total Services
4,491
Medicare Billing
$395,181
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 364 | 761 | $182,500 | $76,156 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 180 | $26,239 | $12,356 | 47.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 49 | 117 | $10,460 | $3,223 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $6,650 | $2,509 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 364 | 832 | $132,800 | $83,022 | 62.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 242 | $26,510 | $17,607 | 66.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 33 | $11,200 | $5,555 | 49.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 35 | 63 | $4,775 | $1,858 | 38.9% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 15 | 15 | $2,250 | $732.33 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 334 | 695 | $110,560 | $71,931 | 65.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 228 | 326 | $34,810 | $22,539 | 64.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 47 | 47 | $16,450 | $8,072 | 49.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 29 | 31 | $4,650 | $2,447 | 52.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $1,100 | $800.00 | 72.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 381 | 762 | $121,860 | $61,539 | 50.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 197 | 274 | $27,400 | $15,605 | 57.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 31 | 31 | $9,350 | $4,711 | 50.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 42 | 52 | $7,800 | $4,519 | 57.9% |
About Dr. Marie-Therese Saky, MD
Dr. Marie-Therese Saky, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194780320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marie-Therese Saky, MD has received a total of $1,263 in payments from pharmaceutical and medical device companies, with $233.97 received in 2024. These payments were reported across 81 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,258).
As a Medicare-enrolled provider, Saky has provided services to 2,496 Medicare beneficiaries, totaling 4,491 services with total Medicare billing of $395,181. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Oakhurst, NJ
- Active Since 04/19/2006
- Last Updated 08/08/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1194780320
Products in Payments
- RYBELSUS (Drug) $139.57
- Victoza (Drug) $121.85
- JANUVIA (Drug) $95.21
- UNITHROID (Drug) $92.23
- FARXIGA (Drug) $92.01
- BYDUREON (Drug) $90.63
- STRENSIQ (Biological) $39.90
- Tirosint (Drug) $39.05
- UBRELVY (Drug) $36.84
- BAQSIMI (Drug) $36.48
- AFREZZA (Drug) $33.79
- Rybelsus (Drug) $30.66
- FREESTYLE LIBRE 3 (Device) $28.91
- FreeStyle Libre 2 (Device) $27.38
- Vascepa (Drug) $26.68
- NATPARA (Drug) $26.42
- JARDIANCE (Drug) $24.83
- Xultophy 100/3.6 (Drug) $22.35
- Ozempic (Drug) $20.67
- ANJESO (Drug) $19.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.